• 首页
  • 身体密码
  • 养生资讯
  • 医学前沿
  • 营养识堂
  • 保健知识
  • 健康饮食

Yiling Pharmaceutical Lianhua Qingwen Capsule helps prevent and control the global epidemic

04-10   

On April 4, 2020, Phoenix TV broadcast a report on Yiling Pharmaceutical. It was reported that the global epidemic continued to worsen. At the China-Europe anti-epidemic exchange meeting, the recovery rate of patients treated with Lianhua Qingwen Capsule of Yiling Pharmaceutical co., LTD was as high as 91.5 percent, which has become a hot spot. Since 2004, Lianhua Qingwen Capsule has been listed by the national health commission of China, the state administration of traditional Chinese medicine and other departments in the treatment of influenza and other respiratory diseases for more than 20 times. It has played an important role in the prevention and control of major epidemics. On March 30, Lianhua Qingwen Capsule was approved by the ministry of health of Thailand for the registration of modern herbal medicine, which indicated that Yiling pharmaceutical co., a representative of modern Chinese medicine enterprises in China, had the qualification to sell Lianhua Qingwen Capsule as a drug in the Thai market.

Lianhua Qingwen Capsule helps prevent and control the global epidemic


At the beginning of 2020, COVID - 19 outbreak occurred in Wuhan, China, as the medicine recommended by the national health commission of China in the "diagnosis and treatment scheme of pneumonia infected by novel coronavirus", the market demand of Lianhua Qingwen capsules (granules) produced by Yiling Pharmaceutical co., LTD surged. In order to ensure market supply and help prevent and control the epidemic, all the production lines of Yiling Pharmaceutical co., ltd. are racing against time to produce Lianhua Qingwen products within 24 hours." When the outbreak came, we immediately donated 10 million yuan of Lianhua Qingwen capsules to the Red Cross society of China, of which 5 million yuan of Lianhua Qingwen capsules were transported overnight to the epidemic area in Wuhan to ensure the market demand. At the same time, we also donated products to foreign countries, such as Iraq and Italy. Yiling Pharmaceutical general manager Wu Xiangjun said in an interview.

In the covid-19 prevention and control programs successively released by more than 20 provinces and cities including Hubei, Guangzhou, Zhejiang, Shandong and Hebei, Lianyanghua Qingwen capsules (granules) are recommended. In an interview, Jia zhenhua, director of the Yiling medical research institute, pointed out that "the formula of Lianhua Qingwen is to include the pathogenesis of such diseases as exogenous febrile diseases (respiratory diseases caused by viruses in western medicine) and its treatment drugs."


The good curative effect of Lianhua Qingwen capsule is due to its characteristic of active intervention in multi-target therapy. Hou Yunlong, deputy director of the new drug evaluation center of Yiling medical research institute, told the reporter: "We found that Lianhua Qingwen has certain antiviral replication ability at the cell. When the virus infects the host cell, the host cell will have a certain immune response, and this immune response will release a number of pro-inflammatory factors.”

The overseas business layout of Yiling keeps accelerating

While actively promoting the fight against the "epidemic", Yiling Pharmaceutical's overseas business layout is also accelerating. On March 30, Yiling pharmaceutical announced that it had obtained the approval from the ministry of health of Thailand for the registration of modern herbal medicine, and approved Lianhua Qingwen capsules to comply with the registration of Thailand's modern herbal medicine standards, which brought more international recognition to traditional Chinese medicine.

"Through this outbreak, there has been a significant change in western European and American countries' understanding of traditional Chinese medicine." Zhao Shaohua, deputy general manager of Yiling Pharmaceutical co., said in an interview, "Lianhua Qingwen has been sold in some countries for many years. It used to be mainly used to treat flu, and there was a normal sale every year. Following the global outbreak of covid-19 this year, the demand for Lianhua Qingwen has increased exponentially. This has laid a very good foundation for Lianhua Qingwen 's future sales in the international market.

At present, Yiling Pharmaceutical products such as Tongxinluo capsule, Lianhua Qingwen capsule, Shensong Yangxin capsule, Qiliqiangxin capsule, Yangzheng Xiaoji capsule have been registered and sold in Korea, Vietnam, Russia, Canada, Singapore, Indonesia and other countries. Tongxinluo capsule has also been included in Vietnam's national health insurance directory. Lianhua Qingwen capsule has been registered in Hong Kong and Macao, as well as in Canada, Mozambique, Indonesia, Brazil, Romania, Thailand and other countries, and has carried out phase II clinical study in the United States.

On the internationalization of traditional Chinese medicine, Wu Xiangjun told reporters: "Yiling Pharmaceutical has set up the world federation of traditional Chinese medicine collateral disease branch, as well as in Canada, Europe, northern Europe. The theory of collateral disease has become a window for the world to understand the culture of traditional Chinese medicine, and a bright spot for the culture of traditional Chinese medicine to enter the world. With the deepening of people's understanding of traditional Chinese medicine and its wide spread, I believe traditional Chinese medicine will be a bright name card for China's internationalization in the future."



免责声明:本文转载自其它媒体,转载目的在于传递更多信息,并不代表本网赞同其观点和对其真实性负责,亦不负任何法律责任。 本站所有资源全部收集于互联网,分享目的仅供大家学习与参考,如有版权或知识产权侵犯等,请给我们留言。

最新

  • 做良心药企,护国民安全

    2022年注定是不平凡的一年,疫情反反复复,各种药品物资紧缺,作为一名医药人,和治药业集团在国内各种物资紧缺,原材料上涨的情况下,依然良心经营,保持药价稳定,不涨价,稳价保供,诚实守信,善心善行。
  • 疫情的潮水褪去,红参在日常生活仍有高光

    维生素C、蒙脱石散、黄桃罐头、布洛芬…… 都曾是疫情期间一物难求的当红健康好物。
  • 为肿瘤MDT度身定制的医院,能将MDT做成什么样?

    “没想到北京美中爱瑞肿瘤医院(以下简称“美中爱瑞”)给我这么大一个阵仗。”走进MDT会议室,卵巢癌复发患者C女士惊讶不已。
  • 祺隆中药——集百草精华、泽万民健康

    祺隆秉承中华数千年的中医药之精髓。一直主张“人与自然”和谐养生的规律,结合现代化科技,传承“国药之文化、健康其百姓”的企业宗旨,诚信立业、开创“祺隆中药”新格局。
  • 深耕感冒药市场取得成果 金石亚药2022年度净利润预增180.16%-296.89%

    1月30日晚间,金石亚药发布2022年度业绩预告。公司预计2022年归属于上市公司股东的净利润约1.86亿元~2.64亿元,同比增长180.16%~296.89%,盈利能力持续改善。
  • 益生蓝:口腔益生菌有没有用?对口腔有哪些效果

    口腔健康是居民身心健康的重要标志,2022年全国爱牙日以“口腔健康 全身健康”为主题,也再一次向大家强调了口腔健康与全身健康之间的关系。
  • 千亿益生菌市场,谁主浮沉

    当人们没有发现微观世界的时候,古人就知道如何食用发酵产品。醋、酒、馒头和酸奶都是经过几千年饮食文化孕育出的微生物产品。古人感知到了这种神奇的物种,并想尽办法将它保存了下来。自古以来古人对于益生菌几千年的认识和研究,也是一然生物这十一年来一直在做的事情。
  • 如何突破中医药发展的瓶颈-解决中药难煎难喝

    2020年中国让全世界意识到中华民族传承积淀千年的中医药力量,中医药行业获得飞速发展的历史契机,但看病,抓药,煎药,难喝过程复杂不符合现代人群的需求,提高中医在大众人群的接受度,将变成新一代中医的使命,中药汤剂,补品的制作工序繁杂,需要耗费大量的时间和精力。
  • 红曲,让高血压、高血脂与你无缘

    随着年龄的增长,很多疾病都会找上门来,而在中老年中最多发的就是高血压。
  • 沙利文发布《2022年中国便携式按摩器品牌洞察报告》,倍轻松为便携式按摩器首创中国品牌

    经历近70年发展,全球按摩器产业链从日本、东南亚逐渐转移至中国;进入21世纪,伴随着中国制造的崛起,中国已经成为全球最大的按摩器产品(大型按摩器和小型便携式按摩器)生产销售市场。21世纪初至今,中国便携式按摩器本土品牌不断涌现,产品高端化发展,便携式按摩器不仅已是逢年过节的送礼好物,更是成为了中国新生代消费群体的“养生工具”。弗若斯特沙利文(Frost & Sullivan, 以下简称“沙利文”),基于一手访谈调研和二手案头研究,发布了《2022年中国便携式按摩器品牌洞察报告》。

友情链接

Back to top
      联系我们   SiteMap